Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

Privacy Policy | Delta Peptides

Information Collection and Use Delta Peptides ("we," "our," or "the Company") is committed to protecting the privacy and security of all users who access our website and services. This privacy policy outlines our practices concerning the collection, use, stora

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Information Collection and Use

Delta Peptides ("we," "our," or "the Company") is committed to protecting the privacy and security of all users who access our website and services. This privacy policy outlines our practices concerning the collection, use, storage, and protection of personal data in compliance with applicable data protection regulations, including the General Data Protection Regulation (GDPR) and other relevant privacy frameworks.

We collect information that you voluntarily provide when using our website, including but not limited to: contact forms, newsletter subscriptions, account registrations, and research inquiries. Personal data collected may include names, email addresses, professional credentials, institutional affiliations, telephone numbers, and IP addresses. Additionally, we automatically collect certain technical information through your browser and device, including access times, pages viewed, referring URLs, and browser type. This information is essential for maintaining operational functionality, improving user experience, and ensuring compliance with applicable regulations governing medical information dissemination.

All data collection serves legitimate business purposes, including responding to inquiries, providing requested information about peptide research, facilitating professional communications, improving our educational content, and maintaining security protocols. We do not collect sensitive health information unless specifically required for research collaboration purposes and with explicit consent.

Legal Basis for Data Processing

Our processing of personal data is conducted under specific lawful bases as required by data protection legislation. We process personal information based on: (1) consent, where you have explicitly agreed to data collection for specific purposes such as newsletter communications or research updates; (2) contractual necessity, where processing is required to fulfill services you have requested; (3) legal obligations, where we must process data to comply with applicable laws and regulations; and (4) legitimate interests, where processing is necessary for our operational requirements and does not override your fundamental rights and freedoms.

For users in the European Economic Area (EEA), United Kingdom, and other jurisdictions with comprehensive data protection laws, we ensure that all processing activities meet the requirements established by the General Data Protection Regulation (GDPR). Our legitimate interests include maintaining website security, preventing fraud, improving our services, conducting business analytics, and providing relevant professional content to medical professionals and researchers. Where we rely on legitimate interests, we conduct balancing assessments to ensure that our interests do not override individual privacy rights.

You have the right to withdraw consent at any time where we are relying on consent as the legal basis for processing. This withdrawal will not affect the lawfulness of processing conducted prior to withdrawal. Please review our contact information for procedures to exercise your rights regarding data processing.

Data Protection and Security Measures

Delta Peptides implements comprehensive technical and organizational security measures designed to protect personal data against unauthorized access, alteration, disclosure, or destruction. Our security infrastructure includes industry-standard encryption protocols for data transmission (TLS/SSL), secure server configurations, regular security audits, access controls limiting personnel data access to authorized individuals only, and continuous monitoring for potential security vulnerabilities.

All personal data is stored on secure servers with restricted access. We employ firewalls, intrusion detection systems, and advanced authentication mechanisms to safeguard data integrity. Our staff members with access to personal information receive regular training on data protection obligations and confidentiality requirements. We maintain documented policies and procedures governing data handling, incident response protocols, and breach notification procedures in accordance with regulatory requirements.

While we implement robust security measures, no internet-based system can be guaranteed completely secure. We cannot warrant absolute security of information transmitted through our website. Users are responsible for maintaining the confidentiality of their account credentials and should immediately notify us of any unauthorized access. In the event of a data breach affecting personal information, we will comply with applicable notification requirements and inform affected individuals within the timeframes mandated by law.

Cookie Policy and Tracking Technologies

Our website utilizes cookies and similar tracking technologies to enhance user experience, analyze website performance, and provide personalized content. Cookies are small text files placed on your device that enable us to recognize repeat visitors, remember preferences, and collect analytics data. We use both session cookies (which expire when you close your browser) and persistent cookies (which remain until deleted or expired).

Categories of cookies we employ include: (1) essential cookies necessary for website functionality and security; (2) analytical cookies that help us understand how visitors interact with our site through services like Google Analytics; (3) functional cookies that remember your preferences and settings; and (4) targeting cookies that may deliver relevant content based on browsing patterns. Essential cookies cannot be disabled as they are critical for site operation, while other cookie categories can be managed through your browser settings.

Most web browsers automatically accept cookies, but you can modify your browser settings to decline cookies or alert you when cookies are being sent. Please note that disabling certain cookies may limit your ability to use specific website features. For detailed information about managing cookies, please consult your browser's help documentation. Third-party analytics providers may also collect information through our website; these providers have their own privacy policies governing data use. By continuing to use our website, you consent to our use of cookies as described in this policy.

Data Sharing and Third-Party Disclosures

Delta Peptides does not sell, rent, or trade personal information to third parties for marketing purposes. We may share personal data with carefully selected third-party service providers who assist in operating our website, conducting business operations, or providing services on our behalf. These service providers include web hosting companies, email service providers, analytics platforms, and IT support contractors. All third-party processors are contractually bound to maintain confidentiality, implement appropriate security measures, and process data only in accordance with our instructions.

We may disclose personal information when required by law, regulation, legal process, or governmental request. This includes compliance with court orders, subpoenas, regulatory investigations, or requests from law enforcement authorities. We may also share information to protect our legal rights, enforce our terms of service, investigate potential fraud or security issues, or protect the safety and security of our users and the public.

In the event of a business transaction such as a merger, acquisition, reorganization, or sale of assets, personal data may be transferred to successor entities. We will provide notice and obtain consent where required by applicable law before transferring data to any acquiring organization. When we transfer data internationally, we ensure appropriate safeguards are in place, including Standard Contractual Clauses approved by regulatory authorities, to protect personal information in accordance with applicable data protection standards.

User Rights and Data Subject Requests

Under applicable data protection laws, you possess specific rights regarding your personal information. These rights include: (1) the right to access personal data we hold about you and receive a copy in a commonly used format; (2) the right to rectification of inaccurate or incomplete personal information; (3) the right to erasure ("right to be forgotten") under certain circumstances; (4) the right to restrict processing where specific conditions apply; (5) the right to data portability, allowing you to receive and transfer your data to another controller; (6) the right to object to processing based on legitimate interests; and (7) the right to withdraw consent where processing is based on consent.

To exercise any of these rights, please submit a written request through our contact page or email our Data Protection Officer at the address provided below. We will respond to verified requests within the timeframes required by applicable law, typically within 30 days. We may request additional information to verify your identity before processing requests to ensure data security and prevent unauthorized disclosures.

Please note that certain rights may be limited under specific circumstances as permitted by law. For example, we may retain certain information where legally required or where necessary for establishing, exercising, or defending legal claims. If we deny a request, we will provide explanation and information about available complaint procedures. You have the right to lodge a complaint with a supervisory authority if you believe our processing of your personal data violates applicable regulations.

Data Retention and Deletion

Delta Peptides retains personal information only for as long as necessary to fulfill the purposes for which it was collected and to comply with legal, regulatory, and contractual obligations. Retention periods vary depending on the type of information and purpose of processing. Generally, we retain contact information and communication records for the duration of our business relationship and for a reasonable period thereafter to address potential inquiries or legal requirements.

Technical data, including log files and analytics information, is typically retained for shorter periods necessary for security monitoring and operational analysis. Marketing communications data is retained until you unsubscribe from our mailing lists, after which it is promptly deleted or anonymized. Account information is maintained while your account remains active and for a limited period following account closure to comply with legal obligations and resolve disputes.

When personal data is no longer required, we implement secure deletion or anonymization procedures to prevent recovery or reconstruction. Our data retention schedules are regularly reviewed and updated to ensure compliance with evolving regulatory requirements. If you wish to request deletion of your personal information before the standard retention period expires, please contact us using the information provided in this privacy policy. We will honor such requests except where retention is required by law or for legitimate business purposes such as fraud prevention or legal defense.

Privacy Policy Updates and Contact Information

Delta Peptides reserves the right to modify this privacy policy at any time to reflect changes in our practices, legal requirements, or operational needs. Material changes will be communicated through prominent notice on our website or via email to registered users. The effective date of the current policy is displayed at the top of this document. We encourage users to periodically review this privacy policy to stay informed about how we protect personal information.

Continued use of our website following policy modifications constitutes acceptance of the revised terms. If you do not agree with updated privacy practices, you should discontinue use of our services and contact us to exercise your data deletion rights where applicable. For users in jurisdictions requiring explicit consent for material changes, we will obtain necessary consent before implementing modifications affecting your personal data.

For questions, concerns, or requests regarding this privacy policy or our data protection practices, please contact our Data Protection Officer at: [email protected]. You may also submit written inquiries to our corporate address provided on our about page. We are committed to addressing privacy concerns promptly and transparently, and we welcome feedback that helps us improve our data protection standards and maintain the trust of the medical professionals and researchers we serve.

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

Related questions

01Frequently Asked Questions: Clinical Information for Healthcare Professionals

This comprehensive resource addresses common peptide questions from medical professionals, clinics, and researchers seeking clinical information and professional guidance on peptide therapeutics. Our evidence-based responses provide the professional guidance necessary for informed clinical decision-making.

Source: deltapeptides.com ↗
comparison

Comparative Analysis: Sermorelin versus Recombinant Human Growth Hormone

The choice between GHRH-based secretagogue therapy (sermorelin) and direct GH replacement (recombinant human growth hormone) represents a fundamental therapeutic decision with distinct mech…

Source: deltapeptides.com
Research context

Read sources and limitations before applying a claim.

Current Clinical Trial Landscape for Peptide Therapeutics

The global clinical trial infrastructure for peptide research has expanded substantially, with ClinicalTrials.gov documenting over 1,200 active peptide-related studies as of 2024. These investigations span Phase I safety assessments through Phase IV post-marketing surveillance, representing investments exceeding $15 billion annually in peptide drug development. The National Institutes of Health clinical trial database reveals concentrated research activity in oncology, metabolic disorders, and cardiovascular disease, with peptide research demonstrating particular promise in previously intractable conditions.

Source: deltapeptides.com ↗

Investigational Cardiovascular Studies

Preclinical models of myocardial ischemia-reperfusion injury have demonstrated that GHSR-1a activation may attenuate apoptotic signalling through PI3K/Akt-dependent pathways. These observations, while encouraging at the bench, have not been translated into approved cardiovascular indications and remain the subject of ongoing research summarized in our cardiovascular peptide applications monograph. The pharmacology described is informative for hypothesis-generating studies but does not establish clinical efficacy or safety.

Source: deltapeptides.com ↗
Practical and safety references

These excerpts are educational, not personalised medical instructions.

Dosage reference

Clinical Dosing Strategies and Treatment Cycles

Established clinical protocols typically employ cyclical dosing regimens to optimize therapeutic effects while minimizing potential risks associated with continuous telomerase activation. Standard treatment cycles involve daily administration of 5-10mg subcutaneously for 10-20 consecutive days, followed by rest periods of 4-6 months. This cyclical approach aligns with observed temporal dynamics of telomerase activation and telomere elongation, allowing for restoration of telomere length during active treatment phases while permitting physiological regulation during rest intervals. Monitoring protocols should include baseline assessment of relevant biomarkers prior to treatment initiation, with follow-up evaluations at cycle completion to guide protocol adjustments and assess individual response patterns.

Source: deltapeptides.com ↗
Storage reference

Storage and Stability

Cerebrolysin solution is stable for 24–36 months when stored at 2–8 °C in its original light-protected container. The preparation should not be frozen, as freezing may induce aggregation of peptide components. After the container is opened, the solution should be used promptly to minimize microbial contamination risk. The storage monograph details the validated container-closure system and temperature ranges supporting the assigned shelf life.

Source: deltapeptides.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →